As pioneers in medical devices, we continually focus on elevating the standard of care – working to expand patient access, improve outcomes, reduce health system costs and drive value. We create smart, people-centered healthcare to help the patients we serve recover faster and live longer and more vibrantly.
We are in this for life.
Let’s change the TRAJECTORY of stroke. We are committed to pushing the boundaries of what is possible in stroke care.
CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. For more information, visit www.cerenovus.com.
Stroke is one of the devastating diseases, robbing people of their independence and their quality of life.
Globally, 1 in 4 adults over the age of 25 will have a stroke in their lifetime1
Stroke claims a life every 5 seconds.2
Stroke is the second leading cause of death globally and results in 50% of survivors being chronically disabled3
Stroke shouldn’t be a life sentence. At CERENOVUS, we are changing the trajectory of stroke.